Literature DB >> 23086583

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier.

Shaheen Alanee1, Sohela Shah, Rajmohan Murali, Rohini Rau-Murthy, Kasmintan A Schrader, Kenneth Offit.   

Abstract

BRCA1 functions as a tumor suppressor gene and germline and somatic mutations in this gene have been shown to be associated with many types of cancer. We report the first tumor study of renal cell carcinoma in a carrier of the deleterious BRCA1 mutation-c.68_69delAG.

Entities:  

Mesh：

Year:  2013        PMID： 23086583      PMCID： PMC5073794          DOI： 10.1007/s10689-012-9572-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


  10 in total

Review 1.  The role of PARP1 in the DNA damage response and its application in tumor therapy.

Authors:  Zhifeng Wang; Fengli Wang; Tieshan Tang; Caixia Guo
Journal:  Front Med       Date:  2012-06-03       Impact factor: 4.592

2.  Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan.

Authors:  Muhammad U Rashid; Sidra Gull; Saima Faisal; Saba Khaliq; Kashif Asghar; Neelam Siddiqui; Asim Amin; Ute Hamann
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

3.  Brca1 controls homology-directed DNA repair.

Authors:  M E Moynahan; J W Chiu; B H Koller; M Jasin
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

4.  Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.

Authors:  M E Moynahan; T Y Cui; M Jasin
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

5.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

6.  Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells.

Authors:  Takahiro Kawakami; Keisei Okamoto; Osamu Ogawa; Yusaku Okada
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 7.  The genetics of breast cancer susceptibility.

Authors:  N Rahman; M R Stratton
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

8.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

9.  Germline BRCA1 mutations increase prostate cancer risk.

Authors:  D Leongamornlert; N Mahmud; M Tymrakiewicz; E Saunders; T Dadaev; E Castro; C Goh; K Govindasami; M Guy; L O'Brien; E Sawyer; A Hall; R Wilkinson; D Easton; D Goldgar; R Eeles; Z Kote-Jarai
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

10.  BAP1 loss defines a new class of renal cell carcinoma.

Authors:  Samuel Peña-Llopis; Silvia Vega-Rubín-de-Celis; Arnold Liao; Nan Leng; Andrea Pavía-Jiménez; Shanshan Wang; Toshinari Yamasaki; Leah Zhrebker; Sharanya Sivanand; Patrick Spence; Lisa Kinch; Tina Hambuch; Suneer Jain; Yair Lotan; Vitaly Margulis; Arthur I Sagalowsky; Pia Banerji Summerour; Wareef Kabbani; S W Wendy Wong; Nick Grishin; Marc Laurent; Xian-Jin Xie; Christian D Haudenschild; Mark T Ross; David R Bentley; Payal Kapur; James Brugarolas
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330
  10 in total
  1 in total

1.  Recent progress on the role and molecular mechanism of chicken ovalbumin upstream promoter-transcription factor II in cancer.

Authors:  Seong-Hoon Yun; Joo-In Park
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.